Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Avenue Therapeutics Inc is a specialty pharmaceutical company that develops and markets pharmaceutical products for the acute care setting. It focuses on developing its product candidate, an intravenous (IV) formulation of tramadol HCI (IV Tramadol), for post-operative acute pain. Avenue Therapeutics Inc is a specialty pharmaceutical company that develops and markets pharmaceutical products for the acute care setting. It focuses on developing its product candidate, an intravenous (IV) formulation of tramadol HCI (IV Tramadol), for post-operative acute pain.
MIAMI, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization...
MIAMI, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.0262 | 2.01538461538 | 1.3 | 1.42 | 1.22 | 110330 | 1.33222313 | CS |
| 4 | -0.5438 | -29.0802139037 | 1.87 | 2.06 | 1.22 | 1286716 | 1.85836208 | CS |
| 12 | -0.6238 | -31.9897435897 | 1.95 | 2.2289 | 1.22 | 422309 | 1.86148966 | CS |
| 26 | -1.2438 | -48.3968871595 | 2.57 | 3.54 | 1.22 | 208108 | 1.91313844 | CS |
| 52 | -9.1738 | -87.3695238095 | 10.5 | 15 | 1.22 | 542427 | 8.66651037 | CS |
| 156 | -853.6738 | -99.8448888889 | 855 | 1406.25 | 1.22 | 1793251 | 308.74064399 | CS |
| 260 | -11642.4238 | -99.9886101986 | 11643.75 | 14130 | 1.22 | 1167891 | 683.37707626 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
